Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

October 22, 2018 17:00 ET | Source: MacroGenics, Inc.

MacroGenics Announces Participation in Three Investor Conferences

ROCKVILLE, MD, Oct. 22, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
September 26, 2018 16:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Participation in Two Upcoming Investor Conferences

ROCKVILLE, MD, Sept. 26, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
August 30, 2018 18:05 ET | Source: MacroGenics, Inc.

MacroGenics Announces Participation in Three Upcoming Investor Conferences

Rockville, MD, Aug. 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
August 09, 2018 18:00 ET | Source: MacroGenics, Inc.

MacroGenics to Present at Wedbush PacGrow Healthcare Conference

ROCKVILLE, MD, Aug. 09, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
August 07, 2018 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and 2nd Quarter 2018 Financial Results

ROCKVILLE, Md., Aug. 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
July 30, 2018 18:35 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of Second Quarter 2018 Financial Results Conference Call

ROCKVILLE, MD, July 30, 2018 (GLOBE NEWSWIRE) -- -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Tuesday, August 7, 2018, the Company will release its financial results for the...
June 05, 2018 16:30 ET | Source: MacroGenics, Inc.

MacroGenics to Present at Jefferies Global Healthcare Conference

ROCKVILLE, MD, June 05, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
May 07, 2018 18:00 ET | Source: MacroGenics, Inc.

MacroGenics to Present at Deutsche Bank Health Care Conference

ROCKVILLE, MD, May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
May 07, 2018 16:01 ET | Source: MacroGenics, Inc.

MacroGenics Provides Update on Corporate Progress and 1st Quarter 2018 Financial Results

ROCKVILLE, Md., May 07, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (NASDAQ:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal...
April 30, 2018 18:30 ET | Source: MacroGenics, Inc.

MacroGenics Announces Date of First Quarter 2018 Financial Results Conference Call

ROCKVILLE, MD, April 30, 2018 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq: MGNX) today announced that on Monday, May 7, 2018, the Company will release its financial results for the quarter ended...